TEE
KRMD icon

Tibra Equities Europe’s KORU Medical Systems KRMD Stock Holding History

Tibra Equities Europe’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-81,100
Closed -$375K – 126
2021
Q2 		$375K Buy
+81,100
New +$318K 0.12% 39

Other funds holding KRMD

HCM
Horton Capital Management Philadelphia, Pennsylvania $44.9M AUM 24.87% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tibra Equities Europe's KRMD Position: Q3 2021 in Review

Tibra Equities Europe sold out of KORU Medical Systems (KRMD) in Q3 2021, closing a stake of 81,100 shares — an estimated $375K sold.

Tibra Equities Europe first reported a position in KRMD in Q2 2021 and held it in 1 quarter. The position peaked at $375K in Q2 2021. 50 funds tracked by Wall St. Rank hold KRMD as of Q3 2021.

  • Tibra Equities Europe reported no remaining KORU Medical Systems position as of Q3 2021 after selling out during the quarter.
  • Tibra Equities Europe sold 81,100 KORU Medical Systems shares in Q3 2021, an estimated $375K.
  • Tibra Equities Europe first reported a position in KORU Medical Systems in Q2 2021 and held it in 1 quarter.
  • Tibra Equities Europe's KORU Medical Systems position peaked at $375K in Q2 2021.
  • 50 funds tracked by Wall St. Rank held KORU Medical Systems as of Q3 2021.

Based on Tibra Equities Europe's 13F filing for Q3 2021, filed 15 Nov 2021.